ezetimibe has been researched along with Cardiac Failure in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, R; Liu, SY; Zhao, LM | 1 |
| Akiba, Y; Fukuda, K; Funahashi, A; Hashimoto, H; Katsuki, T; Kimura, M; Komuro, J; Kuoka, T; Kusumoto, D; Nakamura, T; Seki, T; Tokuoka, Y; Yamada, T; Yuasa, S | 1 |
| Aeschbacher-Germann, M; Aujesky, D; Bauer, DC; Blum, MR; Del Giovane, C; Gencer, B; Kaiser, N; Moutzouri, E; Rodondi, N; Speierer, A | 1 |
| Kuang, H; Li, L; Lu, T; Shou, W; Yi, Q; Zhou, X | 1 |
| Bahlmann, E; Boman, K; Chambers, JB; Gerdts, E; Gohlke-Bärwolf, C; Hochholzer, W; Jander, N; Kaufmann, BA; Minners, J; Neumann, FJ; Nienaber, CA; Pedersen, TR; Ray, S; Rossebo, A; Wachtell, K | 1 |
| Bang, CN; Berg, RM; Boman, K; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Nielsen, OW; Nienaber, CA; Okin, PM; Ray, S; Rossebø, AB; Wachtell, K | 1 |
| Desai, A; Resnic, FS | 1 |
| Antoniades, C; Gounari, P; Kampoli, AM; Papageorgiou, N; Roulia, G; Siasos, G; Stefanadi, E; Stefanadis, C; Stougiannos, P; Tousoulis, D; Tsioufis, C | 1 |
| Nissen, SE; Taylor, AJ | 1 |
| Boman, K; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Kesäniemi, YA; Køber, L; Nienaber, C; Ray, S; Rossebø, AB; Wachtell, K; Willenheimer, R | 1 |
| Leung, AA; van Walraven, C | 1 |
| Fukumoto, Y | 1 |
2 review(s) available for ezetimibe and Cardiac Failure
| Article | Year |
|---|---|
Lipid-Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta-Analysis of Exclusion Criteria.
Topics: Aged; Cholesterol; Dementia; Ezetimibe; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Proprotein Convertase 9 | 2023 |
Reviewing the medical literature: five notable articles in general internal medicine from 2010 and 2011.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Azetidines; Cardiomyopathies; Ezetimibe; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyrazoles; Pyridones; Recurrence; Risk; Seizures; Simvastatin; Ultrasonography; Warfarin | 2012 |
4 trial(s) available for ezetimibe and Cardiac Failure
| Article | Year |
|---|---|
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF.
Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Blood Flow Velocity; Echocardiography; Ezetimibe; Female; Heart Failure; Humans; Male; Prospective Studies; ROC Curve; Simvastatin; Stroke Volume | 2014 |
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Atrial Fibrillation; Azetidines; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Global Health; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Rest; Simvastatin; Survival Rate; Time Factors | 2015 |
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
Topics: Azetidines; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Ezetimibe; Female; Fluorobenzenes; Heart Failure; Humans; Lipids; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasodilation | 2010 |
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Azetidines; Cardiovascular Diseases; Drug Therapy, Combination; Electrocardiography; Ezetimibe; Female; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Prognosis; Simvastatin; Ventricular Dysfunction, Left | 2012 |
6 other study(ies) available for ezetimibe and Cardiac Failure
| Article | Year |
|---|---|
Impact of demographic characteristics and antihyperglycemic and cardiovascular drugs on the cardiorenal benefits of SGLT2 inhibitors in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis.
Topics: Cardiovascular Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diuretics; Ezetimibe; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Meta-Analysis as Topic; Socioeconomic Factors; Sodium-Glucose Transporter 2 Inhibitors; Systematic Reviews as Topic | 2021 |
Development of non-bias phenotypic drug screening for cardiomyocyte hypertrophy by image segmentation using deep learning.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cholesterol; Deep Learning; Drug Evaluation, Preclinical; Endothelin-1; Ezetimibe; Heart Failure; Mice; Myocytes, Cardiac; Rats | 2022 |
Early severe coronary heart disease and ischemic heart failure in homozygous familial hypercholesterolemia: A case report.
Topics: Adolescent; Anticholesteremic Agents; Aspirin; Coronary Disease; Ezetimibe; Female; Heart Failure; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Mutation; Myocardial Ischemia; Platelet Aggregation Inhibitors; Receptors, LDL; Xanthogranuloma, Juvenile | 2018 |
Highlights from the 57th annual scientific session of the American College of Cardiology.
Topics: Aortic Valve; Azetidines; Cardiac Catheterization; Catheter Ablation; Coronary Disease; Drug-Eluting Stents; Ezetimibe; Heart Failure; Heart Valve Diseases; Humans; Mitral Valve Insufficiency; Simvastatin; Surgical Instruments | 2008 |
Preliminary observations from preliminary trial results: have we finally had enough?
Topics: Adult; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cardiovascular Surgical Procedures; Ezetimibe; Heart Failure; Humans; Incidence; Neoplasms; Randomized Controlled Trials as Topic; Reperfusion Injury; Research Design; Simvastatin; Survival Analysis; Treatment Outcome | 2008 |
[Medicines for dyslipidemia].
Topics: Anion Exchange Resins; Arteriosclerosis; Azetidines; Dyslipidemias; Ezetimibe; Fibric Acids; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Nicotinic Acids; Probucol | 2012 |